Gastric Cancer Biomarkers

About Paradise Genomics

Paradise Genomics is a private, pre-revenue diagnostics company leveraging over 30 years of collective founder experience in genomics to discover novel biomarker signatures. The company emerged from GenUs BioSystems, a contract lab with a strong track record, and now aims to validate and commercialize its discoveries through partnerships with diagnostic and pharmaceutical companies. Its core value proposition is a proprietary bioinformatics process that claims unmatched sensitivity and precision in unlocking a unique region of the transcriptome for actionable genomic data.

Therapeutic Areas

Other Gastric Cancer Drugs